Dr. James Rynerson is the Founder of Meibum Scientific and a leading authority in the diagnosis and treatment of dry eye disease and blepharitis. He received his medical degree from the University of Louisville School of Medicine and completed his ophthalmology residency at LSU Shreveport. Dr. Rynerson has been in clinical practice for more than 20 years, with a focused specialization in chronic ocular surface disease.
Through years of private practice, Dr. Rynerson identified consistent patterns of treatment failure in patients with dry eye and blepharitis. These observations led him to investigate the underlying causes of persistent inflammation, culminating in his recognition of biofilm driven disease as the root cause of both conditions. His work contributed to the identification and clinical characterization of Deep Subdermal Blepharitis (DSB) and the development of a biofilm centric disease model that underpins Meibum Scientific’s platform.
Dr. Rynerson is widely recognized for advancing the understanding of dry eye and blepharitis as inflammatory diseases rather than surface lubrication disorders. He lectures internationally, including in Europe and Asia, educating clinicians on disease etiology and mechanism based treatment approaches. He also holds multiple patents related to the treatment of dry eye and blepharitis.
Dr. Rynerson resides in Franklin, Tennessee, with his wife and son.